Latest News about CRSP
Recent news which mentions CRSP
Is Gene Editing Already Leaving CRISPR Therapeutics Behind?
November 21, 2020
From Motley Fool
Benzinga's Top Upgrades, Downgrades For October 23, 2020
October 23, 2020
From Benzinga
60 Biggest Movers From Yesterday
October 22, 2020
From Benzinga
58 Stocks Moving In Wednesday's Mid-Day Session
October 21, 2020
From Benzinga
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
October 21, 2020
From Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
October 16, 2020
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
October 14, 2020
From Benzinga
9 Biotech Stocks With Material Catalysts In Q4
October 13, 2020
From Benzinga
'Fast Money Halftime Report' Picks For October 12
October 12, 2020
From Benzinga
Cramer Weighs In On Virgin Galactic, Boeing And More
October 09, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 5, 2020
October 05, 2020
From Benzinga
Where Will Vertex Pharmaceuticals Be in 5 Years?
October 03, 2020
From Motley Fool
Better Buy: CRISPR Therapeutics vs. Editas Medicine
September 30, 2020
From Motley Fool
3 Stocks That Could Double Your Money
September 24, 2020
From Motley Fool
2 Game-Changing Biotech Stocks That May Make You Rich
September 10, 2020
From Motley Fool
Is CRISPR Therapeutics Stock a Good Buy Now, or Is It Too Late?
September 09, 2020
Tickers
CRSP
From Motley Fool
Is Vertex Pharmaceuticals Stock a Buy?
September 07, 2020
From Motley Fool
Where to Invest $10,000 Right Now
September 04, 2020
From Motley Fool
Stocks That Hit 52-Week Highs On Wednesday
August 19, 2020
From Benzinga
2 Revolutionary Biotech Stocks to Buy Right Now
August 13, 2020
From Motley Fool
How Vertex Pharmaceuticals Wowed With Its Q2 Results
July 31, 2020
From Motley Fool
From Benzinga
If You Invested $100 in CRISPR Therapeutics' IPO, This Is How Much Money You'd Have Now
July 26, 2020
From Motley Fool
From Benzinga
3 Unstoppable Stocks to Buy Before the Next Market Crash
July 25, 2020
From Motley Fool
Is CRISPR Therapeutics Stock a Buy?
July 25, 2020
From Motley Fool
2 Best Gene-Editing Stocks to Buy in July
July 21, 2020
From Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
July 17, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.